Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
Our testers were divided on the taste with some preferring to add to a drink or food, rather than taking directly
Quick Takeaways Retatrutide is a triple-receptor agonist (GLP-1, GIP, glucagon) delivering superior monotherapy weight loss at 2428.7% over 4868 weeks Cagrilintide targets amylin receptors for satiety and gastric emptying, achieving 10.8% weight loss in 26 weeks as a monotherapy Retatrutide provides broader metabolic benefits, including dramatic improvements in HbA1c, blood pressure, waist circumference, insulin sensitivity, and liver fat normalization No head-to-head trials exist yet, but the mechanistic and clinical data strongly favor Retatrutide for total body recomposition Retatrutide vs Cagrilintide: Side-by-Side Comparison What Makes Retatrutide Different Retatrutide isnt just another GLP-1 receptor agonist
Estimated at 58%
Injections : A 500 mg or 1000mg vial is self-administered using a subcutaneous injection over a set period
US$ 24.24
US$ 23.07
US$ 23.98
US$ 26.26
US$ 27.59